Company intelligence
Harmony Biosciences
Committed to developing and delivering new therapeutic options for people living with rare neurological diseases.
About Harmony Biosciences
Harmony Biosciences is a commercial-stage biopharmaceutical company dedicated to developing and delivering innovative therapies for people living with rare and other neurological diseases with unmet medical needs. Guided by empathy, driven by science, and focused on innovation, we combine a strong commercial foundation with a growing pipeline of differentiated programs designed to advance treatment across multiple neurological conditions. By creating long-term value through scientific innovation, operational excellence, and disciplined execution, we invest in our people, our pipeline, and our mission to help improve patients’ lives. Follow us: Instagram → @harmony_biosciences X → @harmonybio #InHarmony #EmpathyAndInnovation View community guidelines: http://bit.ly/4v2Exc8
Verified activity
Signals from Harmony Biosciences
5 published signals
Presence & Recognition
Harmony Biosciences participated in the Underdog Series panel discussion hosted by Life Science Cares Philadelphia featuring Christopher Molineaux Nyree Oliver and Dan Rhoton on how the company contributes to the Greater Philadelphia community.
Reported by Cate McCanless
Presence & Recognition
Harmony Biosciences announced that it will present encore data from its epilepsy pipeline at the 16th European Epilepsy Congress hosted by the International League Against Epilepsy in Athens, Greece.
Reported by Harmony Biosciences
Presence & Recognition
Harmony Biosciences President and CEO Jeffrey M. Dayno, Chief Operating Officer Peter Anastasiou, and Chief Medical and Scientific Officer Kumar Budur, M.D., spoke with Fierce Biotech to discuss the growing momentum around orexin agonists and their potential across CNS disorders.
Reported by Harmony Biosciences
People
Harmony Biosciences is partnering with Michael Faia and the R&D team to identify an experienced Associate Director, R&D Project & Portfolio Management.
Reported by Ellen Mancino
People
Harmony Biosciences has a Market Access professional named Julie Brown leading a team focused on product access for patients.
Reported by Harmony Biosciences